For example, the SNP of FOXA2 at its binding sites attenuates the binding of FOXA2 and ERα to their targets thus influencing hepatocellular carcinoma (HCC) development.6 However, to date, only a modest number of liver cancer-associated SNPs have been identified, and fewer molecular bases have been revealed. This evidence concerns the gene FOXA2 and hepatocellular carcinoma.